DE2449885C3
(de)
*
|
1974-10-21 |
1980-04-30 |
Biotest-Serum-Institut Gmbh, 6000 Frankfurt |
Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
|
US4001200A
(en)
*
|
1975-02-27 |
1977-01-04 |
Alza Corporation |
Novel polymerized, cross-linked, stromal-free hemoglobin
|
US4009267A
(en)
*
|
1975-09-09 |
1977-02-22 |
Diagnostic Data, Inc. |
Cross-linked orgotein
|
CA1055932A
(fr)
*
|
1975-10-22 |
1979-06-05 |
Hematech Inc. |
Succedane du sang comparable a l'hemoglobine
|
US4343715A
(en)
*
|
1980-10-10 |
1982-08-10 |
Duke University |
Immobilized hemoglobin, and processes for extracting oxygen from fluids using the same
|
US4427416A
(en)
|
1980-10-10 |
1984-01-24 |
Duke University |
Processes for extracting oxygen from fluids using immobilized hemoglobin
|
US4473496A
(en)
*
|
1981-09-14 |
1984-09-25 |
The United States Of America As Represented By The Secretary Of The Army |
Intramolecularly crosslinked hemoglobin
|
DE3320752A1
(de)
*
|
1983-06-09 |
1984-12-13 |
Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol |
Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
|
DE3340592A1
(de)
*
|
1983-11-10 |
1985-05-23 |
B. Braun Melsungen Ag, 3508 Melsungen |
Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
|
USRE34271E
(en)
*
|
1984-06-27 |
1993-06-01 |
University Of Iowa Research Foundation |
Production of alpha-alpha cross-linked hemoglobins in high yield
|
US4598064A
(en)
*
|
1984-06-27 |
1986-07-01 |
University Of Iowa Research Foundation |
Alpha-alpha cross-linked hemoglobins
|
US4600531A
(en)
*
|
1984-06-27 |
1986-07-15 |
University Of Iowa Research Foundation |
Production of alpha-alpha cross-linked hemoglobins in high yield
|
US4584130A
(en)
*
|
1985-03-29 |
1986-04-22 |
University Of Maryland |
Intramolecularly cross-linked hemoglobin and method of preparation
|
US5753616A
(en)
*
|
1986-11-10 |
1998-05-19 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
US5955581A
(en)
*
|
1986-11-10 |
1999-09-21 |
Biopure Corporation |
Method for producing a stable polymerized hemoglobin blood-substitute
|
US5189146A
(en)
*
|
1987-05-05 |
1993-02-23 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence |
Pasteurizable, freeze-driable hemoglobin-based blood substitute
|
US5248766A
(en)
*
|
1990-08-17 |
1993-09-28 |
Baxter International Inc. |
Oxirane-modified hemoglobin based composition
|
HUT64571A
(en)
*
|
1990-11-29 |
1994-01-28 |
Upjohn Co |
A method for producing hemoglobin preparatives containing imido ester cross bind
|
US5900477A
(en)
*
|
1992-01-30 |
1999-05-04 |
Baxter International, Inc. |
Use of hemoglobin in the treatment of hemorrhagic shock
|
US5334706A
(en)
*
|
1992-01-30 |
1994-08-02 |
Baxter International |
Administration of low dose hemoglobin to increase perfusion
|
US5591457A
(en)
*
|
1992-02-07 |
1997-01-07 |
Vasogen Inc |
Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
|
US5980954A
(en)
|
1992-02-07 |
1999-11-09 |
Vasogen Ireland Limited |
Treatment of autoimmune diseases
|
US6669965B2
(en)
|
1992-02-07 |
2003-12-30 |
Vasogen Ireland Limited |
Method of treating atherosclerosis
|
GB9617611D0
(en)
*
|
1996-08-22 |
1996-10-02 |
Vasogen Inc |
Treatment of autoimmune disease
|
US5783214A
(en)
*
|
1994-06-13 |
1998-07-21 |
Buford Biomedical, Inc. |
Bio-erodible matrix for the controlled release of medicinals
|
JPH10501823A
(ja)
*
|
1995-04-10 |
1998-02-17 |
バクスター、インターナショナル、インコーポレイテッド |
クモ膜下出血の治療における架橋ヘモグロビンの使用
|
EP0854151A1
(fr)
|
1997-01-20 |
1998-07-22 |
SanguiBioTech AG |
Procédé pour obtenir des fractions uniformes d'hyperpolymères d'hémoglobine
|
US5814601A
(en)
*
|
1997-02-28 |
1998-09-29 |
The Regents Of The University Of California |
Methods and compositions for optimization of oxygen transport by cell-free systems
|
DE69831248T2
(de)
*
|
1997-02-28 |
2006-04-13 |
The Regents Of The University Of California, Oakland |
Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
|
CA2233725A1
(fr)
|
1998-03-31 |
1999-09-30 |
Hemosol Inc. |
Complexes d'amidon hydroxyethyles d'hemoglobine
|
US7271145B2
(en)
*
|
2002-01-11 |
2007-09-18 |
Sangart, Inc. |
Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
|
WO2003059287A2
(fr)
*
|
2002-01-11 |
2003-07-24 |
Sangart, Inc. |
Procedes et compositions de transport d'oxygene comprenant un transporteur d'oxygene et un cristalloide en solution hypertonique
|
SI1465643T1
(sl)
|
2002-01-11 |
2008-06-30 |
Sangart Inc |
Postopki in sestavki za transport kisika z visokoafiniteto za kisik
|
US20030153491A1
(en)
*
|
2002-01-11 |
2003-08-14 |
Winslow Robert M. |
Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
US20050164915A1
(en)
*
|
2002-04-01 |
2005-07-28 |
Sangart, Inc. |
Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
|
JP3912206B2
(ja)
*
|
2002-07-05 |
2007-05-09 |
株式会社日立製作所 |
筒内直接燃料噴射装置用燃料ポンプ
|
US7135554B1
(en)
|
2004-01-27 |
2006-11-14 |
Biopure Corporation |
Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
|
JP2008511674A
(ja)
*
|
2004-08-31 |
2008-04-17 |
サンガート, インコーポレイテッド |
酸素運搬成分を使用して血流力学的安定性を増強する方法
|
US8273857B2
(en)
*
|
2009-09-22 |
2012-09-25 |
Jen-Chang Hsia |
Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
|
US8084581B1
(en)
*
|
2011-04-29 |
2011-12-27 |
Bing Lou Wong |
Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
|
WO2014179793A1
(fr)
|
2013-05-03 |
2014-11-06 |
Washington University |
Composition de succédané de sang et procédé d'utilisation
|
RU2749266C1
(ru)
*
|
2020-02-10 |
2021-06-07 |
Богдан Иванович Асатуров |
Способ получения биоплазмозаменителя гемодинамического действия
|